PASADENA, Calif., March 19, 2015 (GLOBE NEWSWIRE) -- Calhoun Vision, Inc. today announced that Rick A. Heinick has been named Chief Executive Officer and President, effective March 30. Mr. Heinick brings more than 25 years of leadership experience positioning organizations for growth and profitability. Prior to Calhoun, he served as Executive Vice President and Chief Human Resources and Transformation Officer at Bausch + Lomb Incorporated. During his tenure, Mr. Heinick contributed to the company's strong bottom-line performance, culminating in its sale to Valeant Pharmaceuticals in August 2013.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=31520
"Rick's experience and proven leadership ability is crucial to Calhoun as we focus on the vital task of obtaining FDA approval for the Light Adjustable Lens. Rick has a demonstrated track record of forming and leading high performance teams that get results," said Andy Corley, Chairman of Calhoun's board of directors.
"Calhoun's novel LAL technology allows ophthalmologists to tailor the power of an intraocular lens after implantation in the eye following cataract surgery, providing unparalleled customization for patients," said Mr. Heinick. "I look forward to working with the Calhoun team to advance this groundbreaking technology to address unmet needs in ophthalmology, as well as positioning the company for continued growth and success."
Most recently, Mr. Heinick was Executive Vice President of AECOM, where he led the company's human capital area and organizational integration with URS. Earlier in his career, Mr. Heinick served in various entrepreneurial and consulting roles, including Senior Partner at Schaffer Consulting and Founder and CEO of Personal Performance Software.
Mr. Heinick currently serves on the board of directors of Amydis Diagnostics, and has served on the boards of the Association of the Blind and Visually Impaired and the Rochester Business Alliance. He holds an International Masters in Management from McGill University and a Bachelor of Science from Boston University.
About Calhoun Vision
Calhoun Vision, Inc. is a privately held company that is redefining lens implant surgery by developing intraocular lenses that, when combined with a custom-designed digital light source, enable surgeons to change the power of a lens after it has been implanted. This offers the potential to provide unparalleled visual outcomes and customization to the specific visual needs of each patient. Calhoun's Light Adjustable Lens (LAL®) is CE Mark approved in Europe, and is commercially available in Germany, the United Kingdom, France, Italy, Spain, Mexico and the Czech Republic. LAL is currently in a pivotal Phase III clinical trial for astigmatism in the U.S.
Disclaimer: The Light Adjustable Lens (LAL) is an investigational device and is not approved or cleared for sale within the U.S. Limited by Federal law to investigational use.